GLP-1 drugs in a 'survival binder': what's actually worth knowing

What did @itskristybishh actually say?

Honestly? It's not entirely clear. The transcript captured from this video is garbled to the point of being nearly unintelligible, a series of repeated phrases like "I'm not SB" and "I'm SB" with no coherent medical or factual claims embedded in the audio. The caption, however, tells a clearer story: this creator spent roughly 24 hours assembling a "survival binder" for doomsday preparedness scenarios, ranging from economic collapse to zombie apocalypse to CERN-related fears.

The video is categorized under GLP-1 medications, which include semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). If there were GLP-1-specific claims made verbally, the transcript quality makes them impossible to verify directly. What we can fact-check is the broader category context and any implicit framing the video applies to preparedness involving medications.

Does the science back this up?

There is legitimate, evidence-based reason to think about medication supply continuity during emergencies, but the science here depends heavily on what specific claims were being made. GLP-1 receptor agonists require cold storage, which is a real logistical problem in a disaster scenario.

Semaglutide, for example, should be stored between 36-46 degrees Fahrenheit before first use, and once in use, can be kept at room temperature below 77 degrees Fahrenheit for up to 56 days (manufacturer prescribing information, Novo Nordisk, 2023). Tirzepatide has similar storage requirements per Eli Lilly's 2023 prescribing documentation. In a grid-down or supply chain disruption scenario, these requirements create genuine access challenges for the roughly 9 million Americans currently prescribed GLP-1 medications, according to 2024 IQVIA prescription data. A survival binder that accounts for medication logistics is not an absurd idea. Whether this video actually addressed that, we cannot confirm from the transcript.

What did they get wrong (or right)?

Without a legible transcript, it would be unfair to pin specific errors on the creator. The hashtags, though, do some of the talking. Tagging CERN and "zombie apocalypse" alongside legitimate preparedness tags like "shtfprepper" muddles the message. CERN's Large Hadron Collider has been the subject of persistent conspiracy theories claiming it could open dimensional rifts or trigger apocalyptic events. There is no credible scientific basis for these fears. CERN's own safety assessments, peer-reviewed by independent panels, have repeatedly confirmed the collider poses no planetary risk (Ellis et al., 2008, Journal of Physics G).

Economic collapse preparedness, on the other hand, is a more grounded concern. Supply chain disruptions during COVID-19 caused real medication shortages, and GLP-1 drugs were among the most affected, with the FDA listing semaglutide on its drug shortage list from 2022 through portions of 2024. Preparing for pharmacy access disruptions is reasonable. Preparing for zombie attacks is not.

What should you actually know?

If you are on a GLP-1 medication and you are thinking about emergency preparedness, here is what actually matters. First, these drugs are not something you can safely stockpile without proper storage infrastructure. Insulin-dependent diabetics have long faced this problem, and the same logic applies. Second, abruptly stopping GLP-1 therapy carries real consequences: appetite regulation disruption, potential blood sugar instability in type 2 diabetics, and documented rebound weight gain. A 2022 study by Wilding et al. in Diabetes, Obesity and Metabolism found that patients regained roughly two-thirds of lost weight within one year of stopping semaglutide.

Third, compounded versions of semaglutide and tirzepatide that may be cheaper or more accessible are not equivalent to FDA-approved brand-name formulations. The FDA has issued multiple warnings on this. If your survival plan involves switching to compounded peptides during a crisis, that is a clinical decision requiring physician oversight, not a DIY binder entry.

• Talk to your prescriber about emergency supply planning before a crisis hits.
• Ask about a 90-day supply option if your insurance allows it.
• Know your medication's temperature tolerance window and plan accordingly.
• Do not stop GLP-1 therapy abruptly without medical guidance.